Michael Schmidt
Stock Analyst at Guggenheim
(4.93)
# 193
Out of 5,058 analysts
518
Total ratings
53.4%
Success rate
28.7%
Average return
Main Sectors:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintained: Buy | $275 | $199.87 | +37.59% | 25 | Oct 16, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $45 → $18 | $15.09 | +19.28% | 14 | Oct 7, 2026 | |
| GMAB Genmab | Reiterated: Buy | $42 → $54 | $37.80 | +42.86% | 14 | Oct 5, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $28 | $9.87 | +183.69% | 14 | Oct 1, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $35 | $21.90 | +59.82% | 13 | Sep 24, 2026 | |
| CMPX Compass Therapeutics | Rated: Buy | $12 → $4 | $0.9981 | +300.76% | 7 | Sep 22, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $30 → $40 | $17.29 | +131.35% | 2 | Sep 18, 2026 | |
| XFOR X4 Pharmaceuticals | Reiterated: Buy | $12 | $2.77 | +333.21% | 5 | Sep 8, 2026 | |
| ADCT ADC Therapeutics | Rated: Buy | $10 → $5 | $1.27 | +293.70% | 16 | Aug 14, 2026 | |
| PBLS Parabilis Medicines | Reiterated: Buy | $40 | $28.86 | +38.60% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $14.30 | +46.85% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $19.31 | +81.25% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $52 | $30.38 | +71.17% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $14 | $2.56 | +446.88% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.67 | +274.53% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $12 | $7.75 | +54.84% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $78 | $42.39 | +84.01% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $420 → $430 | $362.78 | +18.53% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $58 | $41.43 | +40.00% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $136 → $150 | $112.73 | +33.06% | 43 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.31 | - | 16 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.58 | - | 4 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.80 | - | 7 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $25.59 | +40.68% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.97 | +509.14% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $58.33 | - | 43 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $105.98 | n/a | 6 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $18.74 | n/a | 5 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.029 | n/a | 15 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.96 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.72 | n/a | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.64 | n/a | 9 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $29.64 | n/a | 2 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.51 | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.83 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.46 | n/a | 6 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7451 | n/a | 4 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.00 | n/a | 7 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $43 | $17.37 | n/a | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 | $6.25 | n/a | 6 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $11.98 | n/a | 3 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.29 | n/a | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.40 | n/a | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $63 | $31.72 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $402.60 | n/a | 2 | Sep 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $24.36 | n/a | 13 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.45 | n/a | 2 | Jun 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $140 → $85 | $9.50 | n/a | 5 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.32 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $23 | $23.06 | n/a | 10 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $15 | $0.8331 | n/a | 5 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $4.48 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $0.0002 | n/a | 6 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $44.00 | n/a | 9 | Oct 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $223.94 | n/a | 12 | Oct 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $1.5 | $1.07 | n/a | 5 | Sep 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.6499 | n/a | 8 | Sep 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.37 | n/a | 3 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $3.52 | n/a | 3 | Aug 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.65 | n/a | 4 | Oct 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $177 → $181 | $231.39 | n/a | 5 | Aug 6, 2014 |
Revolution Medicines
Oct 16, 2026
Maintained: Buy
Price Target: $275
Current: $199.87
Upside: +37.59%
ArriVent BioPharma
Oct 7, 2026
Maintained: Buy
Price Target: $45 → $18
Current: $15.09
Upside: +19.28%
Genmab
Oct 5, 2026
Reiterated: Buy
Price Target: $42 → $54
Current: $37.80
Upside: +42.86%
Monte Rosa Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $28
Current: $9.87
Upside: +183.69%
Tango Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: $35
Current: $21.90
Upside: +59.82%
Compass Therapeutics
Sep 22, 2026
Rated: Buy
Price Target: $12 → $4
Current: $0.9981
Upside: +300.76%
BlossomHill Therapeutics
Sep 18, 2026
Reiterated: Buy
Price Target: $30 → $40
Current: $17.29
Upside: +131.35%
X4 Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $12
Current: $2.77
Upside: +333.21%
ADC Therapeutics
Aug 14, 2026
Rated: Buy
Price Target: $10 → $5
Current: $1.27
Upside: +293.70%
Parabilis Medicines
Aug 14, 2026
Reiterated: Buy
Price Target: $40
Current: $28.86
Upside: +38.60%
Aug 12, 2026
Reiterated: Buy
Price Target: $20 → $21
Current: $14.30
Upside: +46.85%
Aug 12, 2026
Reiterated: Buy
Price Target: $35
Current: $19.31
Upside: +81.25%
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $52
Current: $30.38
Upside: +71.17%
Aug 7, 2026
Reiterated: Buy
Price Target: $15 → $14
Current: $2.56
Upside: +446.88%
Aug 7, 2026
Reiterated: Buy
Price Target: $10
Current: $2.67
Upside: +274.53%
Aug 6, 2026
Reiterated: Buy
Price Target: $14 → $12
Current: $7.75
Upside: +54.84%
Aug 5, 2026
Reiterated: Buy
Price Target: $80 → $78
Current: $42.39
Upside: +84.01%
Aug 5, 2026
Reiterated: Buy
Price Target: $420 → $430
Current: $362.78
Upside: +18.53%
Aug 5, 2026
Reiterated: Buy
Price Target: $42 → $58
Current: $41.43
Upside: +40.00%
Jul 28, 2026
Reiterated: Buy
Price Target: $136 → $150
Current: $112.73
Upside: +33.06%
Jul 17, 2026
Rated: Hold
Price Target: n/a
Current: $7.31
Upside: -
Jul 1, 2026
Rated: Hold
Price Target: n/a
Current: $2.58
Upside: -
Jun 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.80
Upside: -
May 5, 2026
Reiterated: Buy
Price Target: $36
Current: $25.59
Upside: +40.68%
Mar 11, 2026
Reiterated: Buy
Price Target: $12
Current: $1.97
Upside: +509.14%
Feb 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $58.33
Upside: -
Aug 11, 2025
Reiterated: Buy
Price Target: $60
Current: $105.98
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $10
Current: $18.74
Upside: n/a
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.029
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $12.96
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $18.72
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $3.64
Upside: n/a
Oct 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $29.64
Upside: n/a
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.51
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.83
Upside: n/a
Jan 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.46
Upside: n/a
Dec 20, 2023
Rated: Hold
Price Target: n/a
Current: $0.7451
Upside: n/a
Dec 7, 2023
Reiterated: Buy
Price Target: n/a
Current: $9.00
Upside: n/a
Oct 3, 2023
Reiterated: Buy
Price Target: $40 → $43
Current: $17.37
Upside: n/a
Jun 27, 2023
Downgraded: Hold
Price Target: $20
Current: $6.25
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $15
Current: $11.98
Upside: n/a
Jan 3, 2023
Downgraded: Hold
Price Target: n/a
Current: $2.29
Upside: n/a
Apr 28, 2021
Downgraded: Hold
Price Target: n/a
Current: $1.40
Upside: n/a
Feb 25, 2021
Reiterated: Buy
Price Target: $66 → $63
Current: $31.72
Upside: n/a
Sep 18, 2020
Reiterated: Hold
Price Target: n/a
Current: $402.60
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $44
Current: $24.36
Upside: n/a
Jun 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $25.45
Upside: n/a
Sep 17, 2018
Initiated Coverage: Buy
Price Target: $140 → $85
Current: $9.50
Upside: n/a
Nov 30, 2016
Reiterated: Buy
Price Target: n/a
Current: $1.32
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $27 → $23
Current: $23.06
Upside: n/a
Nov 11, 2016
Reiterated: Hold
Price Target: $1.5 → $15
Current: $0.8331
Upside: n/a
Nov 10, 2016
Reiterated: Hold
Price Target: $5
Current: $4.48
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $3 → $2
Current: $0.0002
Upside: n/a
Oct 9, 2016
Reiterated: Hold
Price Target: $36
Current: $44.00
Upside: n/a
Oct 5, 2016
Reiterated: Hold
Price Target: $40
Current: $223.94
Upside: n/a
Sep 20, 2016
Reiterated: Hold
Price Target: $4 → $1.5
Current: $1.07
Upside: n/a
Sep 6, 2016
Reiterated: Buy
Price Target: $18
Current: $0.6499
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: n/a
Current: $12.37
Upside: n/a
Aug 16, 2016
Reiterated: Buy
Price Target: $28
Current: $3.52
Upside: n/a
Oct 6, 2015
Reiterated: Buy
Price Target: n/a
Current: $41.65
Upside: n/a
Aug 6, 2014
Rated: Buy
Price Target: $177 → $181
Current: $231.39
Upside: n/a